CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes SVP and Chief Development Off. gave up 132,700 shares (to pay taxes)
- 4 Option exercise Sr. VP & Corp. Secretary acquired 400 shares (option exercise)
- 4 Open-market sale Director sold 6,222 shares at $4.45 ($27,688)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 51,813 shares at $7.72 ($399,996)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award SVP and Chief Development Off. acquired 10,000 shares (grant or award)
- 4 Grant or award Sr. VP & Corp. Secretary acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
Page 22 of 26 · 512 filings